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Abstract 
 
Objective: To assess 5 physical signs to see whether they can assist in the screening of 
patients with CFS/ME, and potentially lead to quicker treatment.  
Methods: This was a diagnostic accuracy study with inter-rater agreement assessment.  
Participants recruited from 2 NHS hospitals, local CFS/ME support groups and the 
community were examined by three practitioners on the same day in a randomized order. 
Two Allied Health Professionals (AHPs) performed independent examinations of physical 
signs including; postural/mechanical disturbances of the thoracic spine, breast varicosities, 
tender Perrin’s Point, tender coeliac plexus and dampened cranial flow. A physician 
conducted a standard clinical neurological and rheumatological assessment, whilst looking 
for patterns of illness behaviour. Each examination lasted approximately 20 minutes. 
Results: Ninety-four participants were assessed, 52 CFS/ME patients and 42 non-CFS/ME 
controls, aged 18-60. Cohen’s kappa revealed agreement between the AHPs was substantial 
for presence of the tender coeliac plexus (κ=0.65, p<0.001) and moderate for 
postural/mechanical disturbance of the thoracic spine (κ=0.57, p<0.001) and Perrin’s point 
(κ=0.56, p<0.001). A McNemar’s test found no statistically significant bias in the diagnosis 
by the experienced AHP relative to actual diagnosis, (p=1.0) and a marginally non-significant 
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bias by the newly trained AHP, p=0.052. There was however, a significant bias in the 
diagnosis made by the physician relative to actual diagnosis, (p<0.001), indicating poor 
diagnostic utility of the clinical neurological and rheumatological assessment.  
Conclusions: Using the physical signs appears to improve the accuracy of identifying people 
with CFS/ME and shows agreement with current diagnostic techniques, however the present 
study concludes that only 2 of these may be needed. Examining for physical signs is both 
quick and simple for the AHP and may be used as an efficient screening tool for CFS/ME.  
This is a small single centre study and therefore further validation in other centres and larger 
populations is needed. 
 
Strengths and Limitations: 
 
 This is the first study that explores agreement on the presence of physical signs in the 
screening of CFS/ME patients and demonstrates proof-of-concept of these signs. 
 This study did not assess the performance of physical signs in diagnosing CFS/ME 
amongst people reporting with illness in clinical practice. 
 The screening method did not involve patient/family history, patient symptoms or any 
discussion between practitioner and patient; including these would be likely to increase 
accuracy in clinical practice. 
 There were more female participants than males, at a rate similar to other studies, which 
have found a higher prevalence of CFS/ME in females; however, there were similar 
percentages of males and females amongst the controls. 
 This was a small study which included only two AHPs using the Perrin technique and did 
not include participants with severe CFS/ME; this limits the generalisation of the 
findings. 
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Introduction 
 
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is characterised by severe, 
debilitating fatigue that is exacerbated by exercise, but does not improve with rest. This 
condition can lead to a substantial impairment, making every day activities difficult. There is 
currently no universally accepted method of diagnosing CFS/ME, so other conditions with a 
similar presentation of symptoms must first be ruled out. Therefore the diagnosis of CFS/ME 
can often be a long process.  
 
Up until recently the most widely accepted criteria for CFS/ME was the revised United States 
Centres for Disease Control and Prevention (CDC) definition [1], which required at least a 
six month period of fatigue that significantly interferes with a person’s everyday activities. In 
addition to this, four or more of the following symptoms must have persisted or reoccurred 
within the last six months; impaired memory or concentration, post-exertion malaise, sore 
throat, tender lymph nodes, aching or stiff muscles, joint pain, headache and unrefreshing 
sleep. The latest internationally recognized diagnostic criteria for CFS/ME is the International 
Consensus Criteria [2] based on the widely adopted Canadian Criteria [3]. 
 
The Canadian criteria included many of the cardiopulmonary and neurological abnormalities, 
which were not included in the CDC criteria. In addition, the Canadian criteria selected cases 
with less psychiatric co-morbidity, more physical functional impairment, more 
fatigue/weakness, plus neurological symptoms, which were significantly different from 
psychiatric controls with CFS/ME [4]. However, in the UK, The National Institute for Health 
and Care Excellence (NICE) recognises the heterogeneity of the condition advising that 
diagnosis of CFS/ME should be made after other possible diagnoses have been excluded and 
the symptoms have persisted for at least four months. The NICE guidance also states that 
diagnosis should be reassessed if none of the following key features of the disorder are 
present; post exertional fatigue, cognitive difficulties, sleep problems or chronic pain [5].  
 
Due to the heterogeneity of the disorder, the aetiology of CFS/ME remains unknown with 
many theories surrounding the pathophysiology of the disorder [6]. The literature suggests 
that a range of possible causes including hormonal disturbances, immune system dysfunction, 
infectious and viral agents and nervous system abnormalities may all play a role in the 
pathophysiology of the disease [7]. Early research suggested that infectious agents such as the 
Epstein-Barr virus (EBV) are associated with CFS/ME, with a persisting EBV infection being 
seen in those with the condition [8]. A number of other infectious agents have been linked to 
the onset of CFS/ME including enteroviruses, which could explain the gastrointestinal 
symptoms often seen in patients [9], and also the acute B19 virus infection [10]. It has been 
suggested that viral infections can alter immune response which in turn, can chronically 
activate the immune system [11] and lead to many of the symptoms associated with CFS/ME. 
However, the research within this field is inconsistent with no evidence of a single infection 
causing CFS/ME, as well as many patients showing no sign of previous infection [12], 
suggesting infectious agents may only be relevant to a subset of the patient population. 
 
Lymphatic system alterations are suggested to have involvement in CFS/ME with 
dysfunction within the immune system, causing toxic build up within the central nervous 
system (CNS) and leading to engorgement of varicose lymph vessels that can be felt on 
examination [13]. Tender lymph nodes are included in the ICC, Canadian, States Centres for 
Disease Control and Prevention (CDC) definitions [1] and the NICE guidance [5] confirming 
it is a common symptom of the disorder related to immune system abnormalities. Techniques 
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to target these engorgements and stimulate the drainage of toxins in the lymph nodes has 
been shown to lead to symptom improvement in patients with CFS/ME [13]. 
   
Currently there is no definitive way of diagnosing patients, although recent research has 
suggested that there is a link between CFS/ME, the lymphatic drainage system and the CNS 
and that, in fact, CFS/ME patients have certain physical signs present that may explain a 
number of the characteristics of the condition [13]. The Perrin technique is a system of 
manual diagnosis and treatment, that is based on the hypothesis that CFS/ME is a disorder of 
the lymphatic drainage of the central nervous system which leads to five physical signs [14].  
 
The first aim of this study was to see whether the five physical signs of the Perrin Technique 
can assist in the screening of patients with CFS/ME, which could then subsequently lead to 
quicker treatment. Secondly, the study aimed to see whether the diagnostic accuracy was 
similar for a newly trained allied health professional with no prior experience of CFS/ME 
compared to an experienced allied health professional.   
 
Methods 
This was a diagnostic accuracy study with inter-rater agreement assessment. The study 
received ethical approval from NRES Committee North West - Lancaster, REC reference 
12/NW/0877, R&D approval was also obtained from each participating NHS trust. The full 
study protocol has been made available at the same publisher. 
 
Recruitment 
CFS/ME participants were recruited from 2 hospital clinics and local support groups within 
the North West. Social media and posters displayed around the University of Central 
Lancashire were used to advertise the study. Healthy participants were recruited from non-
blood relatives and friends of people with CFS/ME, staff and students from the university, 
and from those who had heard about the study over social media. All participants voluntarily 
contacted the research team, by email, telephone or post, to register their interest.  
 
Those who contacted the researcher were sent a participant information sheet via email or 
post. Potential participants were given time to consider participation, during which they could 
contact the researcher to ask any questions about the research. The researcher then sent out a 
consent form to each person, which were then returned if they were happy to take part. 
 
Participant eligibility 
On receiving their completed consent form, the researcher contacted each person by 
telephone in order to assess their eligibility to take part in the study. Potential participants 
who were aged between 18 and 60, were assessed using two forms: a recruitment screening 
form based on the NICE guidance [5], and a form based on the International Consensus 
Criteria [2] (reference standard). These eligibility criteria were used to ensure that each 
CFS/ME patient had received a correct diagnosis of CFS/ME and to ensure that control 
participants did not have undiagnosed CFS/ME. 
 
Inclusion Criteria for CFS/ME group 
 
To be included CFS/ME patients needed to have a prior formal diagnosis of CFS/ME [5] at 
an NHS hospital specialised clinic, persistent or recurrent fatigue for at least the past 6 
months, a clear starting point to the fatigue, the fatigue should be unexplained by any other 
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conditions, the fatigue should reduce the amount of physical activity each person could do, 
the fatigue should feel worse after physical activity.  
 
Additionally CFS/ME patients needed to have at least one of the following symptoms: 
difficulty sleeping or insomnia, joint pain without swelling, headaches, painful lymph nodes 
that are not enlarged, recurrent sore throats, muscle pain without swelling, poor mental 
function, such as difficulty thinking, symptoms getting worse after physical or mental 
exertion, feeling unwell or having flu-like symptoms, dizziness or nausea or heart 
palpitations. 
 
Exclusion Criteria for both CFS/ME and Control groups 
 
The following were excluded from taking part: people needing to use a wheelchair and 
pregnant and lactating women. In addition: comorbidities including: Anaemias, autoimmune 
diseases, cardiac disease, endocrine disorders, infectious diseases, intestinal diseases, 
malignancies, neurological disorders, primary psychiatric disorders, significant pulmonary 
disease, primary sleep disorders. Additional exclusion criteria for control group included: a 
diagnosis of CFS/ME or a family history of CFS/ME. 
 
Each participant was allocated a participant ID number with the clinical team being blinded 
to the groupings.  
 
 
Assessment methods: 
 
Perrin Technique: 
 
The examination comprised the following four assessments:  
 
A. Participant standing: observation and palpation of thoracic spine for any postural 
defects; regions of redness, temperature change or skin rashes or eruptions e.g. 
acne/boils. 
B. Participant lying supine: observation and palpation of breast tissue for varicosities in 
the surface lymphatics and abnormal breast tenderness at ‘Perrin’s Point’ which is a 
superficial tender area found at around 2-3 cm lateral and superior to the left nipple 
[15]. 
C. With the participant remaining supine, palpation of the region of the coeliac plexus 
just below the xiphoid in the upper central area of the abdomen for any abnormal 
tenderness with possible temperature change in the region. 
D. With the participant remaining in a supine position, cradle the head and examine the 
quality of the cranial rhythmic impulse [16]. 
These assessments resulted in identification of the following signs as present or not present; 
1) postural/mechanical disturbances of the thoracic spine (assessment A); 2) breast 
varicosities (assessment B); 3) tender Perrin’s Point (assessment B); 4) tender coeliac plexus 
(assessment C); and 5) dampened cranial flow (assessment D).  
 
If all five signs were present then the participant is classified as having CFS/ME. If one or 
more of the signs was absent, then the participant is classified as not having CFS/ME [16]. 
 
6 
 
The examination was performed by two Allied Health Professionals.  One had 10 years of 
experience of using the Perrin technique and working with CFS/ME patients (experienced 
AHP); the other was newly trained in the Perrin technique with no prior experience of 
CFS/ME (newly trained AHP). The newly trained AHP received training, especially for this 
study, which involved being taught how to examine patients for the 5 physical signs, and 
having hand-on experience of practicing the technique. 
 
Rheumatological Assessment: 
 
A standard clinical neurological and rheumatological assessment was performed by a 
physician whilst observing the participant for any signs of illness behaviour, but no clinical 
history was taken. The neurological examination included muscle strength testing, 
examination of muscle tone in arms and legs, coordination including the finger nose test, 
heel-shin test, heel-toe walking, reflexes and sensation with eyes closed. The rheumatological 
examination examined joint swelling, wasting of regional muscles, deformity of joint, redness 
in joints or tendons, and the palpation of the margin of joints in hands and feet.  
 
If all the tests were normal with no observed illness behaviour, the patient was classified as 
not having CFS/ME, whereas if abnormal observations were made, the physician used their 
clinical experience to decide if the participant had CFS/ME. The physician performing these 
assessments had experience of working in NHS clinics for CFS/ME but had no experience of 
the Perrin technique (physician).  
 
 
Data collection 
 
For each participant, all data collection was performed on a single assessment day.  They 
were allowed to bring a friend or relative along for support, or if requested, a chaperone was 
provided by the research team. Participants were re-briefed on what would be involved and 
consent was confirmed.  
 
Each of the participants were separately examined by the three practitioners in different 
rooms; The order of examinations was randomised.  No conversation took place between the 
participants and practitioners except to determine if there was any pain or tenderness in 
certain regions.  
 
Data analysis 
 
A priori, the Perrin technique required all five symptoms to be present for a patient to be 
diagnosed as CFS/ME. Using this criterion, the sensitivity and specificity of the diagnosis of 
CFS/ME relative to the reference standard were estimated as simple proportions, accompanied 
by exact (binomial) 95% confidence intervals. McNemar’s test was used to investigate whether 
any of the practitioners systematically under- or over-diagnosed CFS/ME. Agreement in the 
diagnosis of CFS/ME between AHPs using the Perrin Technique was estimated using Cohen’s 
Kappa () coefficient; an approximate 95% confidence interval for  was obtained using bias-
corrected non-parametric bootstrapping. Agreement between their identification of the 
individual physical signs was also estimated using the same methods. 
 
Exploratory analysis of the performance of using different numbers of symptoms was then 
performed.  Symptoms were removed based on the observed agreement between AHPs; so the 
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four-symptom test excluded the symptom with lowest agreement, the three-symptom test 
excluded the two symptoms with the two lowest agreements, and so on. 
 
Sample size 
 
The target sample size was 50 with CFS/ME and 50 controls to enable estimation of sensitivity 
and specificity of each Perrin technique AHP’s diagnosis of CFS/ME (relative to the imperfect 
reference standard) to within ±9.9% with 95% confidence if the sensitivity and specificity were 
each at least 85%. It would also enable the estimation of  (for inter-rater agreement between 
each pair), with 95% confidence, to within ±0.140 providing  were at least 0.7. 
 
Results 
 
Ninety-four participants were recruited: 52 CFS/ME patients and 42 non-CFS/ME controls. 
The gender ratio in the CFS/ME group (shown in table 1) is in keeping with epidemiological 
studies which have shown a larger number of CFS/ME patients to be female with a ratio of 
2:1 or more [17]. Results show that, on average, the experienced AHP was most accurate 
(86%) at correctly diagnosing participants. This was followed by the newly trained who 
correctly diagnosed 77%, and the physician who correctly diagnosed 69% of participants.  
 
 CFS/ME Control 
Male 9 (17%) 25 (60%) 
Female 43 (83%) 17 (40%) 
Table 1: Gender balance of the two groups 
 
Sensitivity and Specificity: 
Table 2 shows the prevalence, sensitivity (the proportion of positive results in people with 
CFS/ME), specificity (the proportion of negative CFS/ME results in healthy controls), 
positive predictor value (the proportion with CFS/ME in participants with a positive result) 
and negative predictive value (the proportion of healthy controls with negative CFS/ME 
results). 
 
Practitioner True 
Positives 
False 
Negatives 
False 
Positives 
True 
Negatives 
Sensitivity Specificity Positive 
Predictive 
Value 
Negative 
Predictive 
Value 
Accuracy 
(%) 
Experienced 
AHP 
46 6 7 35 0.88 0.83 0.87 0.85 86.2 
Newly 
trained AHP 
36 16 6 36 0.69 0.86 0.86 0.69 76.6 
Physician 23 29 0 42 0.44 1.00 1.00 0.57 69.1 
Table 2: Diagnostic performance of the three practitioners 
 
When using the five physical signs of the Perrin Technique, the sensitivity for the 
experienced AHP was 0.88 (95% CI 0.77 to 0.96) and the specificity was 0.83 (95% CI 0.69 
to 0.93). Similarly, when the newly trained AHP used the same technique, the specificity was 
0.86 (95% CI 0.71 to 0.95), however sensitivity was lowered to 0.69 (95% CI 0.55 to 0.81). 
This shows that although using the same technique, the newly trained AHP struggled more 
frequently to identify correctly all five physical signs in people with a positive diagnosis of 
CFS/ME.  There was no statistically significant bias in the diagnosis by the experienced AHP 
relative to actual diagnosis (p = 1.0). There was also a marginally non-significant evidence of 
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biased diagnosis by the newly trained AHP relative to actual diagnosis (p = 0.052) potentially 
favouring a non-CFS/ME diagnosis. 
 
When using the standard clinical neurological and rheumatological examination, the 
sensitivity of the physician was 0.44 (95% CI 0.30 to 0.59) and the specificity was 1.0 (95% 
CI 0.92 to 1.0). These results show that whilst able to identify correctly all healthy controls, 
the physician struggled the most out of all three practitioners to identify correctly people with 
a positive diagnosis of CFS/ME.  There was a significant bias in the diagnosis by the 
physician relative to actual diagnosis (p < 0.001), also favouring a non-CFS diagnosis.  
 
Agreement between the experienced and newly trained AHPs 
 
There was moderate agreement between the experienced and newly trained AHPs on overall 
diagnosis using the 5 physical signs of the Perrin Technique (κ = 0.56, 95% CI 0.40 to 0.72, p 
<0.001).  Regarding the identification of the individual physical signs, there was substantial 
agreement between the AHPs on the presence of the tender coeliac plexus (κ = 0.65; 95% CI 
0.48 to 0.80, p < 0.001) and agreement was moderate both on the presence of 
postural/mechanical disturbance of the thoracic spine (κ = 0.57; 95% CI 0.39 to 0.73, p < 
0.001) and on the presence of Perrin’s point (κ = 0.56; 95% CI 0.37 to 0.73, p < 0.001). 
However, there was only fair agreement between the AHP’s identification of the dampened 
cranial flow (κ = 0.35; 95% CI 0.15 to 0.54, p = 0.001) and there was non-significant ‘slight’ 
agreement on the presence of breast varicosities (κ = 0.03; 95% CI -0.12 to 0.22, p = 0.75). 
 
Diagnostic properties of alternative criteria 
 
Given the relatively low sensitivity for the newly trained AHP, alternative criteria were 
applied using lower number of physical signs. Using the Kappa statistics for agreement 
between the experienced and newly trained AHPs on the presence of the Perrin technique 
physical signs, each physical sign, in order starting with the sign with the least agreement, 
was excluded and sensitivity and specificity were recalculated. Overall, the AHPs were more 
accurate at diagnosing participants when using only 2 of the 5 signs (tender coeliac plexus 
and postural/ mechanical disturbance of the thoracic spine). Tables 3 and 4 show the accuracy 
of the experienced and newly trained AHPs, respectively, when using each number of 
physical signs. The accuracy of the experienced AHP is the same using 3-5 of the physical 
signs (86.2%) with the highest accuracy using only 2 of the physical signs (88.3%). The 
accuracy of the newly trained AHP is highest using only 1 or 2 of the physical signs (80.9%). 
Therefore, accuracy for both AHPs, overall, is highest when using only tests of tender coeliac 
plexus and postural/ mechanical disturbance of the thoracic spine. 
 
Table 3: Experienced AHP 
Number 
of Items 
True 
Positives 
False 
Positives 
True 
Negatives 
False 
Negatives 
Sensitivity Specificity Positive 
Predictive 
Value 
Negative 
Predictive 
Value 
Accuracy 
(%) 
5* 46 7 35 6 0.88 0.83 0.87 0.85 86.2 
4* 46 7 35 6 0.88 0.83 0.87 0.85 86.2 
3* 46 7 35 6 0.88 0.83 0.87 0.85 86.2 
2* 48 7 35 4 0.92 0.83 0.87 0.90 88.3 
1* 49 12 30 3 0.94 0.71 0.80 0.91 84.0 
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Table 4: Newly trained AHP 
 
Number 
of Items 
True 
Positives 
False 
Positives 
True 
Negatives 
False 
Negatives 
Sensitivity Specificity Positive 
Predictive 
Value 
Negative 
Predictive 
Value 
Accuracy 
(%) 
5* 36 6 36 16 0.69 0.86 0.86 0.69 76.6 
4* 36 7 35 16 0.69 0.83 0.84 0.69 75.5 
3* 40 7 35 12 0.77 0.83 0.85 0.74 79.8 
2* 42 8 34 10 0.81 0.81 0.84 0.77 80.9 
1* 48 14 28 4 0.92 0.67 0.77 0.88 80.9 
5* includes all 5 Perrin technique physical signs; 4* includes postural/mechanical disturbances of the thoracic spine, tender 
Perrin’s Point, tender coeliac plexus, dampened cranial flow; 3* includes postural/mechanical disturbances of the thoracic 
spine, tender Perrin’s Point, tender coeliac plexus; 2* includes tender coeliac plexus and postural/mechanical disturbance of 
the thoracic spine; 1* includes tender coeliac plexus. 
 
Cohen’s κ was re-computed for the level of agreement between the experienced and newly 
trained AHPs on whether they believed the 94 individuals had CFS/ME or were healthy 
controls, using the reduced 2 physical signs of the Perrin Technique. There was substantial 
agreement between the two AHPs on overall diagnosis using the 2 physical signs, κ = 0.61 
(95% CI, 0.45 to 0.74), p < 0.001. There was no statistically significant bias in the diagnosis 
by the experienced AHP and actual diagnosis (p = 0.55), or by the newly trained AHP and 
actual diagnosis (p = 0.63) when using the reduced 2 item Perrin Technique, showing that the 
revised criteria no longer favoured a non-CFS/ME diagnosis. 
 
Discussion 
 
Between the AHPs, the AHP with prior experience of using the Perrin technique was the 
most accurate at correctly diagnosing individuals with CFS/ME, whereas the AHP with no 
prior experience of CFS/ME or the Perrin technique was better at correctly recognising 
healthy individuals.  
 
The AHP experienced in the Perrin technique, was able to identify 88% of patients with 
CFS/ME using all five physical signs, and 83% of healthy controls who did not display all 
five signs. However, for the AHP with no prior Perrin technique experience, they were able 
to detect 86% of healthy controls, but identified only 69% of patients with CFS/ME using all 
five signs; there was borderline non-significant evidence of this AHP underdiagnosing rather 
than over-diagnosing CFS/ME. This highlights that the newly trained AHP was not able to 
identify all 5 signs in some people with a diagnosis of CFS/ME. However, this does not 
necessarily mean that the signs were not present; it could mean that the newly trained AHP 
found these signs more difficult to detect. Despite this, there was moderate agreement 
between both AHPs on overall diagnosis.  
 
The physician was able to correctly identify 100% of the healthy controls using the standard 
clinical neurological and rheumatological examination. However, they were only able to 
correctly identify 44% of patients with CFS/ME and the tendency to under-diagnose CFS/ME 
was highly statistically significant (p<0.001). This affirms the current approach used in CFS 
diagnostics based on NICE guidance in that clinical examination is most useful in identifying 
alternative diagnoses and to exclude the diagnosis of CFS/ME, but that clinical examination 
is not a useful modality for confirming diagnosis of CFS/ME. 
 
The agreement of the AHPs on the presence of each of the five physical signs varied from 
substantial agreement on the presence of the tender coeliac plexus to non-significant ‘slight’ 
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agreement on the presence of breast varicosities. From the results presented, it would seem 
that the physical signs can improve the accuracy of diagnosing CFS/ME, although not all of 
the 5 physical signs may be necessary. Even with the experienced AHP, who, on the whole, 
was able to identify the 5 signs, breast varicosities and dampened cranial flow did not 
improve accuracy of diagnosis. Further exploration of the sensitivity, specificity and accuracy 
found that using only 2 of the 5 physical signs (tender coeliac plexus and postural/mechanical 
disturbance of the thoracic spine) was the most accurate and efficient method of correctly 
diagnosing the participants for both AHPs despite their differing levels of prior experience of 
CFS/ME and the Perrin technique.  
 
Previous work [15] found Perrin’s point to have a diagnostic accuracy of 80% in patients 
with CFS/ME. This was very similar to the accuracy when including Perrin’s point in the 
current study (Accuracy; experienced AHP = 86.2% and newly trained AHP = 79.8%). 
However it was found that the omission of Perrin’s point marginally increased the accuracy 
of the AHP with prior experience of the Perrin Technique by 2.1% and the AHP with no prior 
experience of the Perrin Technique by 1.1%.  
 
Limitations and suggestions for future research 
 
Although this study shows clearly that diagnostic accuracy for CFS/ME increases using the 
physical signs of the Perrin technique, there are some limitations, which should be 
highlighted. Firstly, this study recruited two groups of participants, people with a prior 
diagnosis of CFS/ME and healthy controls with no symptoms of the condition, as the purpose 
was to establish ‘proof-of-concept’ of the Perrin technique. Therefore, the study did not 
explore how accurate the Perrin Technique physical signs would be, when presented with 
patients with different conditions with similar presenting symptoms such as fibromyalgia. 
However, in a clinical setting, knowing the history and symptoms together with the physical 
signs would help to differentially diagnose CFS/ME from other possible illnesses.  Now that 
we have established proof-of-concept, it will be important to identify whether the physical 
signs of the Perrin technique, combined with history, 
 
The gender balance in the CFS/ME patients was similar to that of previously published work 
[17], although the healthy volunteers were recruited as a convenience sample which was not 
gender matched, therefore any prior knowledge of the expected male-female ratio amongst 
CFS/ME patients could have influenced the results. It should be noted, however, that none of 
the practitioners knew if the control group was matched or not for gender and that the AHP 
with no prior experience of CFS/ME was unaware of the gender balance. Although all 
participants were aged between 18 and 60, individual age data was not collected for each 
participant. However, it is reported that CFS/ME develops more commonly in those between 
their mid-twenties and mid-forties [18]. 
 
Future research should investigate whether the physical signs are more apparent in people 
with more severe CFS/ME. The present study did not collect data how long each participant 
had had CFS/ME for or on the severity of their symptoms, which could add further 
understanding. 
 
Only 3 practitioners (1 in each category) were used.  We therefore have very limited 
information on agreement between practitioners and whether diagnostic accuracy is 
substantially affected by experience; we have no information on within-category variation. 
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Future research should involve a study design whereby there are multiple experienced AHPs, 
newly trained AHPs and physicians. 
 
A further limitation is that we selected specific symptoms for exclusion from the diagnostic 
criterion based on the agreement between practitioners.  This was a pragmatic decision based 
on the estimated agreement between practitioners; it does not invalidate our findings, but 
there may be alternative criteria which have better performance.  Again, optimisation of the 
set of symptoms for diagnosis merits further investigation in a larger study, in which 
additional information around acceptability and performance of individual physical sign 
assessments could be performed. 
 
Conclusion 
 
Current methods for diagnosing CFS/ME are challenging. The use of standard clinical 
neurological and rheumatological examination to examine illness behaviour is more likely to 
have a false negative result than a true positive one. Using certain physical signs appears to 
improve the accuracy of identifying people with CFS/ME and shows agreement with current 
diagnostic techniques, although not all of the physical signs were useful, and it is suggested 
that only 2 of these are needed. Examining for physical signs is both quick and simple for the 
AHP and may be used as an efficient screening tool for CFS/ME. This study did not include 
patient/family history or the patient talking about their symptoms, which should increase 
accuracy in clinical practice. 
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